Bruceantin, a novel inhibitor of peptide bond formation.
D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D006160:Guanosine Triphosphate / Q000378:metabolism; D007700:Kinetics; D010452:Peptide Biosynthesis; D010616:Phenanthrenes / Q000494:pharmacology*; D014176:Protein Biosynthesis / Q000187:drug effects*; D036702:Quassins; D012156:Reticulocytes / Q000378:metabolism; D012270:Ribosomes / Q000378:metabolism; D012441:Saccharomyces cerevisiae / Q000378:metabolism; D013045:Species Specificity; D014243:Trichodermin / Q000494:pharmacology
D000972:Antineoplastic Agents, Phytogenic; D010616:Phenanthrenes; D036702:Quassins; D014243:Trichodermin; D006160:Guanosine Triphosphate; C002550:bruceantin